Condition
Cardiomyopathy, Hypertrophic clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Cardiomyopathy, Hypertrophic clinical trials that are recruiting, at sites in 4 countries (most in China (2), Brazil (1), Germany (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 4Countries
Newest Cardiomyopathy, Hypertrophic clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Mavacamten plus supervised exercise for people with obstructive hypertrophic cardiomyopathy | — | Munich, Bavaria | Recruiting | Jul 22, 2025 |
| Registry for hereditary cardiovascular diseases in Brazil | — | Rio Branco, Acre and 26 other locations | Recruiting | Aug 9, 2024 |
| Identifying cardiac amyloidosis in older adults with lumbar spinal stenosis | — | Beverly Hills, California and 5 other locations | Recruiting | Sep 13, 2023 |
| Comparing hybrid and catheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy | — | Beijing | Recruiting | Nov 9, 2022 |
| Observational study on hypertrophic cardiomyopathy in Chinese patients | — | Beijing, Beijing Municipality | Recruiting | Mar 2, 2016 |
All recruiting trials (5)
-
Mavacamten plus supervised exercise for people with obstructive hypertrophic cardiomyopathy
This trial tests whether supervised moderate endurance and resistance training is safe and improves fitness for adults with obstructive hypertrophic cardiomyopathy who have been on stable mavacamten treatment.
-
Registry for hereditary cardiovascular diseases in Brazil
This study is trying to create a registry of Brazilian patients with hereditary heart diseases to see how common certain genetic changes are in people with these conditions.
-
Identifying cardiac amyloidosis in older adults with lumbar spinal stenosis
This study is trying to find out if older adults who have had surgery for lumbar spinal stenosis also have a heart condition called transthyretin cardiac amyloidosis by looking at their spinal tissue and using advanced technology.
-
Comparing hybrid and catheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy
This study is testing whether a new hybrid ablation method works better than traditional catheter ablation for controlling heart rhythm in patients with hypertrophic cardiomyopathy and ongoing atrial fibrillation.
-
Observational study on hypertrophic cardiomyopathy in Chinese patients
This study is trying to understand hypertrophic cardiomyopathy in Chinese patients by collecting health information and samples to see how genetics and other factors play a role in the condition and its risks.
Related topics
Quick answers
How many Cardiomyopathy, Hypertrophic clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in China (2 trials), Brazil (1 trial), Germany (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.